InspireMD, Inc. — Director's Dealing 2021

Feb 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2021-02-08

Reporting Person: Kester Thomas J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-08	Common Stock	P	120960	$0.62	Acquired	331593	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-08	Warrants	$0.682	P	60480	Acquired	2026-02-08	Common Stock (60480)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Optins to purchase common stock (right to buy)	$0.39	2030-08-31	Common Stock (52686)	52686	Direct

Footnotes

F1: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 120,960 shares of common stock and warrants to purchase 60,480 shares of common stock together, as part of 120,960 units, at a purchase price of $0.62 per unit.

F2: The Reporting Person has not engaged in any reportable transactions with respect to these derivative securities of the Issuer and is including his ownership of these securities for informational purposes only in this Form 4.

F3: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.